J Gynecol Oncol.  2025 Jan;36(1):e3. 10.3802/jgo.2025.36.e3.

Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis

Affiliations
  • 1Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine and Faculty of Medicine, Sapporo, Japan
  • 2University of Pennsylvania, School of Veterinary Medicine, Biomedical Science, Philadelphia, PA, USA
  • 3Department of Gynecologic Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan
  • 4Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
  • 5Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan
  • 6Department of Obstetrics and Gynecology, International University of Health and Welfare, Narita, Japan
  • 7Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan
  • 8Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan
  • 9Department of Obstetrics and Gynecology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, Japan
  • 10Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan
  • 11Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
  • 12Department of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan
  • 13Akasaka Sanno Medical Center, Tokyo, Japan
  • 14International University of Health and Welfare, Graduate School, Tokyo, Japan

Abstract


Objective
This study aimed to determine whether the number of resected pelvic lymph nodes (PLNs) affects the prognosis of endometrial cancer (EC) patients at post-operative risk of recurrence.
Methods
JGOG2043 was a randomized controlled trial to assess the efficacy of three chemotherapeutic regimens as adjuvant therapy in EC patients with post-operative recurrent risk. A retrospective analysis was conducted on 250 patients who underwent pelvic lymphadenectomy alone in JGOG2043. The number of resected and positive nodes and other clinicopathologic risk factors for survival were retrieved.
Results
There were 83 patients in the group with less than 20 PLNs removed (group A), while 167 patients had 20 or more PLNs removed (group B). There was no significant difference in patients’ backgrounds between the two groups, and the rate of lymph node metastasis was not significantly different. There was a trend toward fewer pelvic recurrences in group B compared with group A (3.5% vs. 9.6%; p=0.050). Although Kaplan-Meier analysis showed no statistically significant difference in survival rates between the two groups (5-year overall survival [OS]=90.3% vs. 84.3%; p=0.199), multivariate analysis revealed that resection of 20 or more nodes is one of the independent prognostic factors (hazard ratio=0.49; 95% confidence interval=0.24–0.99; p=0.048), as well as surgical stage, high-risk histology, and advanced age for OS.
Conclusion
Resection of 20 or more PLNs was associated with improved pelvic control and better survival outcomes in EC patients at risk of recurrence who underwent pelvic lymphadenectomy alone and were treated with adjuvant chemotherapy.

Keyword

Endometrial Neoplasms; Cohort Studies; Lymph Node Excision; Multivariate Analysis
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr